{"id":10072,"date":"2023-06-21T06:59:42","date_gmt":"2023-06-20T20:59:42","guid":{"rendered":"https:\/\/doseme-rx.com\/?page_id=10072"},"modified":"2023-07-25T02:09:57","modified_gmt":"2023-07-24T16:09:57","slug":"oncology","status":"publish","type":"page","link":"https:\/\/doseme-rx.com\/en-gb\/why-dosemerx\/oncology","title":{"rendered":"Oncology"},"content":{"rendered":"\r\n
\r\n
<\/div>\r\n
\r\n \n\n

ONCOLOGY MODELS<\/p>\n\n\n\n

Streamline oncology TDM with cutting-edge dosing software.<\/h1>\n\n\n\n

Trust the leader in precision dosing to optimize utlitization of essential chemotherapy agents.<\/p>\n\n\n\n

\n
Request a demo<\/a><\/div>\n\n\n\n
Talk to a human<\/a><\/div>\n<\/div>\n\n\r\n <\/div>\r\n<\/div>\n\n\n
\n
\n

Supporting you in delivering high-quality evidence-based medicine.<\/h2>\n\n\n\n

Our team of bioinformaticians, scientists, and clinical pharmacists meticulously select the best clinically-validated PK\/PD models for DoseMeRx. View DoseMeRx drug models for all therapeutic areas here<\/a>. <\/p>\n\n\n\n

DoseMeRx oncology drug models for adult and pediatric patients: <\/h3>\n<\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\r\n
\r\n \n\n
\n

Currently available<\/h3>\n<\/div><\/div>\n\n\n\n
\n

Busulfan <\/p>\n\n\n\n

Busulfan Oral <\/p>\n\n\n\n

Carboplatin <\/p>\n\n\n\n

Cyclosporine Oral <\/p>\n\n\n\n

Imatinib Mesylate <\/p>\n\n\n\n

Methotrexate  <\/p>\n<\/div><\/div>\n\n\r\n<\/div>\n\n\n

<\/div>\n\n\n\r\n
\r\n \r\n<\/div><\/div>\n\n\n\n
\r\n
\r\n \n\n
\n

Available on request<\/h3>\n<\/div><\/div>\n\n\n\n
\n

Velcade (Bortezomib) <\/p>\n\n\n\n

Fludarabine<\/p>\n\n\n\n

<\/p>\n<\/div><\/div>\n\n\r\n<\/div><\/div>\n<\/div>\n\n\n\n

<\/div>\n<\/div><\/div>\n\n\n\n
\n
\n

Simplify busulfan dosing for providers & patients with only two levels<\/h2>\n\n\n\n

Busulfan dosing is a complex process due to various factors that impact its effectiveness and safety.\u00a0<\/p>\n\n\n\n

Busulfan drug exposure must be maintained within a narrow therapeutic range. If the drug exposure is too high, there is an increased risk of toxicity and of transplantation-related mortality. If the dose is too low, there is an increased probability of graft rejection or disease relapse. Additionally, accurately estimating the AUC and adjusting the dosage accordingly can be difficult.<\/p>\n\n\n\n

Conventional methods of dosing busulfan also require multiple blood samples, typically around 5-8, to measure AUC. This frequent sampling is not only time-consuming for providers, but also increases patient discomfort.<\/p>\n\n\n\n

There\u2019s an easier way to dose! The challenges of busulfan dosing emphasize the need for advanced tools and technology, such as DoseMeRx<\/a>, to simplify the dosing process and reduce the burden on patients. <\/p>\n\n\n\n

A study<\/a> comparing the conventional multi-sample AUC estimation model of busulfan dosing in HCT patients with a two-sample protocol using DoseMeRx, found that DoseMeRx:<\/p>\n\n\n\n